Condition
Multiple System Atrophy (MSA) clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Multiple System Atrophy (MSA) clinical trials that are recruiting, at sites in 4 countries (most in China (3), United States (2), Sweden (1)). By phase: Early Phase 1 (3), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Multiple System Atrophy (MSA) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Imaging with MODAG-009 PET to See Synuclein in PD, MSA, and Healthy Adults | Early Phase 1 | New Haven, Connecticut | Recruiting | Jun 10, 2026 |
| SST001 PET tracer safety and pharmacokinetics in healthy adults and people with PD or MSA | Phase 1 | Wuxi, Jiangsu and 1 other locations | Recruiting | May 22, 2026 |
| MSA-01 to try to slow progression of Multiple System Atrophy | Phase 3 | Nagoya, Aichi-ken and 11 other locations | Recruiting | Mar 3, 2026 |
| Using AI to improve the levodopa challenge test for Parkinson's disease diagnosis | — | Beijing | Recruiting | Apr 29, 2025 |
| Testing a new PET tracer for measuring brain protein in neurodegenerative diseases | Early Phase 1 | Solna | Recruiting | Mar 24, 2025 |
| Aleeto for Parkinsonian multiple system atrophy (MSA-P) | Early Phase 1 | Beijing, Beijing Municipality | Recruiting | Jan 9, 2025 |
| Multidisciplinary care for patients with Multiple System Atrophy | — | Dallas, Texas | Recruiting | Jan 22, 2019 |
All recruiting trials (7)
-
Imaging with MODAG-009 PET to See Synuclein in PD, MSA, and Healthy Adults
This study tests a new PET tracer, MODAG-009, in people with Parkinson's, Multiple System Atrophy, and healthy adults to see how well it images synuclein in the brain.
-
SST001 PET tracer safety and pharmacokinetics in healthy adults and people with PD or MSA
This study tests SST001, a PET tracer, to see if it is safe and how it behaves in the body for healthy adults and people with Parkinson’s disease or multiple system atrophy.
-
MSA-01 to try to slow progression of Multiple System Atrophy
This trial will test whether MSA-01 (a bioavailable form of CoQ10) can slow motor worsening in people with probable or established MSA over 52 weeks.
-
Using AI to improve the levodopa challenge test for Parkinson's disease diagnosis
This study is testing a new way to diagnose Parkinson's disease using artificial intelligence and video recordings to see if it can improve the accuracy of the levodopa challenge test.
-
Testing a new PET tracer for measuring brain protein in neurodegenerative diseases
This study is testing a new imaging tool to see if it can help detect a specific brain protein in people with conditions like Parkinson's Disease and Dementia.
-
Aleeto for Parkinsonian multiple system atrophy (MSA-P)
This study will test whether Aleeto is safe and might help people with the Parkinsonian form of multiple system atrophy.
-
Multidisciplinary care for patients with Multiple System Atrophy
This study looks at how well specialized care helps people with Multiple System Atrophy feel and live better, while also checking how it affects their caregivers over five years.
Related topics
Quick answers
How many Multiple System Atrophy (MSA) clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in China (3 trials), United States (2 trials), Sweden (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 3, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.